$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Adagrasib dosage and usage
2026-02-01 22:25:32
Check Details
Comparison of Adagrasib and Sotoracib
2026-02-01 22:25:32
Check Details
The efficacy of Adagrasib in the treatment of lung cancer
2026-02-01 22:25:32
Check Details
Warnings and Precautions for Using Adagrasib
2026-02-01 22:25:32
Check Details
How long should I take Adagrasib?
2026-02-01 22:25:32
Check Details
How long does it take to become resistant to Adagrasib?
2026-02-01 22:25:32
Check Details
Epclusa latest Chinese manual
2026-02-01 22:25:32
Check Details
Avatrombopag instructions
2026-02-01 22:25:32
Check Details
What is Avatrombopag?
2026-02-01 22:25:32
Check Details
What are the precautions for Avatrombopag?
2026-02-01 22:25:32
Check Details
Avatrombopag efficacy
2026-02-01 22:25:32
Check Details
Avatrombopag release date
2026-02-01 22:25:32
Check Details
1
2
...
299
300
301
302
303
304
305
...
10210
10211
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Enfortumab Vedotin (Padcev): Nectin-4-Targeted ADC for Advanced Urothelial Carcinoma
2
Urece (Dotinurad): Highly Selective URAT1 Inhibitor for Gout and Hyperuricemia
3
Mirvetuximab Soravtansine (Elahere): FRα-Targeted ADC for Platinum-Resistant Ovarian Cancer
4
The Cornerstone Therapy for Adrenocortical Carcinoma and Global Guidelines Update
5
Anagrelide (Agrylin): Managing ET-Related Thrombocytosis
6
Trodelvy® (Sacituzumab Govitecan-hziy): A Life-Changing ADC for Advanced Cancers
7
Azacitidine Treatment Guide: Indications, Cross-Border Purchase & Safety Tips
8
Odevixibat: Targeting IBAT to Transform Cholestatic Liver Disease Treatment
9
A Precision FGFR Inhibitor for Cholangiocarcinoma
10
A Revolutionary Targeted Therapy for Hematological Malignancies
11
A New Option for Advanced Renal Cell Carcinoma Treatment
12
Trametinib (Mekinist): Precision MEK1/2 Inhibition Transforming Cancer Care Short Description: